Search Results 31-40 of 16309 for Chronic Lymphocytic Leukemia

  1. Chronic lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Learn about this cancer that forms in white blood cells called lymphocytes. Treatments include chemotherapy, targeted therapy and immunotherapy.

  2. A Study to Evaluate the Effectiveness and Safety of Panzyga in Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    Diagnosis of B-cell CLL established according to International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria and documented within medical records.

  3. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    This study is designed to evaluate PFS endpoint for acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia. Participation eligibility.

  4. Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Dr. Cerhan's NHL & CLL case-control study at Mayo Clinic tests hypotheses about the etiology of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

  5. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL ...

  6. Acute Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  7. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    ... Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating ...

  8. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

    About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...

  9. 3 facts about acute lymphocytic leukemia in children - Mayo Clinic News Network

    Here's what she wants families to know about this disease: 1. ALL is rare and has a collection of persistent symptoms. In 2023, the American Cancer Society ...

  10. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia. Monoclonal antibodies, such as rituximab, can ... chronic lymphocytic leukemia. Participation eligibility. Participant ...